WWC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.814000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.368400E-01
Normal-vs-Stage2
9.067000E-01
Normal-vs-Stage3
5.523600E-01
Normal-vs-Stage4
5.311400E-01
Stage1-vs-Stage2
9.030400E-01
Stage1-vs-Stage3
2.128200E-01
Stage1-vs-Stage4
1.389020E-01
Stage2-vs-Stage3
2.717200E-01
Stage2-vs-Stage4
2.749400E-01
Stage3-vs-Stage4
9.905000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.851200E-01
Normal-vs-AfricanAmerican
8.090800E-01
Normal-vs-Asian
8.094800E-01
Caucasian-vs-AfricanAmerican
8.916200E-01
Caucasian-vs-Asian
6.462800E-01
AfricanAmerican-vs-Asian
8.566800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.778400E-01
Normal-vs-Female
8.850400E-01
Male-vs-Female
9.319800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.458800E-01
Normal-vs-Age(41-60Yrs)
9.775600E-01
Normal-vs-Age(61-80Yrs)
8.262000E-01
Normal-vs-Age(81-100Yrs)
6.912400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.831200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.404060E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.801600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.809900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.089500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.858210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.286800E-01
Normal-vs-Daily Drinker
8.817400E-01
Normal-vs-Weekly Drinker
8.714600E-01
Normal-vs-Occasional Drinker
8.386600E-01
Normal-vs-Social Drinker
8.987200E-01
Non Drinker-vs-Daily Drinker
8.769600E-01
Non Drinker-vs-Weekly Drinker
7.383800E-01
Non Drinker-vs-Occasional Drinker
9.060800E-01
Non Drinker-vs-Social Drinker
3.281800E-01
Daily Drinker-vs-Weekly Drinker
8.307600E-01
Daily Drinker-vs-Occasional Drinker
7.739400E-01
Daily Drinker-vs-Social Drinker
3.907800E-01
Weekly Drinker-vs-Occasional Drinker
6.511200E-01
Weekly Drinker-vs-Social Drinker
5.835800E-01
Occasional Drinker-vs-Social Drinker
2.970600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.926400E-02
Normal-vs-Grade 2
2.548100E-02
Normal-vs-Grade 3
3.544300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.114200E-01
Grade 1-vs-Grade 3
1.639770E-01
Grade 1-vs-Grade 4
8.926400E-02
Grade 2-vs-Grade 3
2.035600E-01
Grade 2-vs-Grade 4
2.548100E-02
Grade 3-vs-Grade 4
3.544300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.853000E-01
Normal-vs-NonDiabetic
9.587400E-01
Diabetic-vs-NonDiabetic
1.046610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.793400E-01
Normal-vs-NoPancreatitis
8.878600E-01
Pancreatitis-vs-NoPancreatitis
4.736000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.606200E-01
Normal-vs-N1
9.364000E-01
N0-vs-N1
5.580300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.528800E-01
Normal-vs-TP53-NonMutant
9.967400E-01
TP53-Mutant-vs-TP53-NonMutant
1.969250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
